Diligence memo · auto-generated · as of July 2, 2026
Volta Labs, Inc.
Volta Labs, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Volta Labs, Inc. operates in Biotech, based in BOSTON, MA, USA. Unlocking the utility of genomics for the world.
Sub-sector tags: Biotechnology, Genomics, Hard Tech, Hardware, Robotics, biotech, energy.
Capital & rounds (filed)filed
Volta Labs, Inc. has raised $38M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2022-01-27.
Most recent recorded round closed around 2023-12-29.
Valuation (modeled)modeled
Provath models Volta Labs, Inc. at approximately $112M (range $25M–$222M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.73× the median modeled value of Series B Biotech companies in 2022–2024 (7 peers) — value vs value, same stage and era. Within the normal band (73% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 2.5 yr ago; this sector typically re-raises about every 11 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 3.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 95% of Biotech peers (233 compared).
Modeled value ranks above 89% of those peers.
Closest niche peers: Watchmaker Genomics, Inc., Mytos, Inc., ZBiotics Co, Siren Biotechnology, Inc., Invert, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.